Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
General Internal Medicine
•
Rheumatology
•
Vasculitis
Would you give IVIG for Rituximab induced immunodeficiency in patients with reduced kidney function from renal GPA?
Related Questions
How do you approach worsening memory loss in patients with GCA?
How do you treat IgA vasculitis with gastrointestinal involvement?
Do you have to extend treatment for acute Lyme disease if a patient is on high dose steroids for another indication?
What is your approach to methotrexate use (or avoidance) in patients with varying MTHFR mutations?
Do you seek pathologic confirmation before proceeding with empiric immunosuppressive therapy in symptomatic patients with radiographic NSIP?
How do you approach tapering of tocilizumab used for a history of GCA with vision loss?
When stopping denosumab and transitioning to PO bisphosphonate, do you wait for 6 months after the last denosumab injection to start PO bisphosphonate?
Would you add a DMARD such as methotrexate for a patient with GCA and partial response to tocilizumab but inability to taper prednisone below 10mg daily?
How would you treat a patient with osteoarthritis of just one joint of the hand?
What are some practical tips in distinguishing between metabolic bone disease due to chronic kidney disease and osteoporosis?
